iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Whittier Trust Co.

Whittier Trust Co. trimmed its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.4% during the 1st quarter, Holdings Channel reports. The fund owned 6,053 shares of the financial services provider’s stock after selling 86 shares during the quarter. Whittier Trust Co.’s holdings in iShares Biotechnology ETF were worth $774,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Bank of America Corp DE increased its stake in iShares Biotechnology ETF by 6.5% during the fourth quarter. Bank of America Corp DE now owns 7,489,427 shares of the financial services provider’s stock worth $990,177,000 after acquiring an additional 460,154 shares during the last quarter. Main Management ETF Advisors LLC lifted its holdings in shares of iShares Biotechnology ETF by 3.2% in the 4th quarter. Main Management ETF Advisors LLC now owns 612,180 shares of the financial services provider’s stock valued at $80,936,000 after purchasing an additional 18,810 shares during the last quarter. Focus Partners Wealth increased its position in iShares Biotechnology ETF by 168.2% in the 4th quarter. Focus Partners Wealth now owns 121,996 shares of the financial services provider’s stock valued at $16,485,000 after acquiring an additional 76,509 shares during the period. Madrona Financial Services LLC increased its position in iShares Biotechnology ETF by 153.0% in the 1st quarter. Madrona Financial Services LLC now owns 81,150 shares of the financial services provider’s stock valued at $10,379,000 after acquiring an additional 49,075 shares during the period. Finally, Appleton Partners Inc. MA increased its position in iShares Biotechnology ETF by 3.4% in the 1st quarter. Appleton Partners Inc. MA now owns 78,382 shares of the financial services provider’s stock valued at $10,025,000 after acquiring an additional 2,579 shares during the period. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.4%

NASDAQ IBB opened at $131.74 on Friday. The business’s 50 day moving average is $125.83 and its two-hundred day moving average is $129.02. iShares Biotechnology ETF has a 12-month low of $107.43 and a 12-month high of $150.57.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.